Nevro (NVRO) Announces Roderick MacLeod as CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
June 4, 2020 7:00 AM EDTREDWOOD CITY, Calif., June 4, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Roderick ("Rod") MacLeod as Chief Financial Officer, effective June 15, 2020, with global responsibility for Finance, IT and Customer Service. Mr. MacLeod succeeds Andrew Galligan, who is retiring but will remain with the Company during a transition period.
"Rod is a proven leader with a track record of success in finance and operations leadership. We are... More



